Inventor · disambiguated record
Luigi Manenti
Also filed as: MANENTI LUIGI
1 granted patent·8 pending applications·0 citations·filing 2013–2020
8Inventor score
Top patents by PatentIndex Score
9 records- 0149US2023057071A1Combination of anti tim-3 antibody mbg453 and anti tgf-beta antibody nis793, with or without decitabine or the anti pd-1 antibody spartalizumab, for treating myelofibrosis and myelodysplastic syndromeNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0246US2022340685A1Combination therapy with entpd2 and cd73 antibodiesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0346US2022348651A1Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapiesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0445US2020223924A1Dosage regimens for anti-tim-3 antibodies and uses thereofNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0543US2020101077A1Combination therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0639US2013273032A1Predictive biomarker for cancer treatment with adcc-enhanced antibodiesROCHE GLYCART AG·Filed 2013·Application pending·0 cites
- 0739US2013195854A1Predictive biomarker for cancer treatment with adcc-enhanced antibodiesROCHE GLYCART AG·Filed 2013·Application pending·0 cites
- 0835US2017224692A1Combination TherapyHAO HUAIXIANG·Filed 2015·Application pending·0 cites
- 0932US11229643B2Combinations of FGFR4 inhibitors and bile acid sequestrantsNOVARTIS AG·Filed 2017·Granted Jan 25, 2022·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Luigi Manenti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →